MX2017008162A - Sintesis total de trioxacarcina dc-45-a2 y preparacion de analogos de trioxacarcina. - Google Patents

Sintesis total de trioxacarcina dc-45-a2 y preparacion de analogos de trioxacarcina.

Info

Publication number
MX2017008162A
MX2017008162A MX2017008162A MX2017008162A MX2017008162A MX 2017008162 A MX2017008162 A MX 2017008162A MX 2017008162 A MX2017008162 A MX 2017008162A MX 2017008162 A MX2017008162 A MX 2017008162A MX 2017008162 A MX2017008162 A MX 2017008162A
Authority
MX
Mexico
Prior art keywords
trioxacarcin
analogs
preparation
total synthesis
methods
Prior art date
Application number
MX2017008162A
Other languages
English (en)
Inventor
C Nicolaou Kyriacos
Cai Quan
Original Assignee
Univ Rice William M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rice William M filed Critical Univ Rice William M
Publication of MX2017008162A publication Critical patent/MX2017008162A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)

Abstract

En un aspecto, la presente invención proporciona derivados novedosos de análogos de trioxacarina de la fórmula (I) (ver Fórmula) en donde las variables son como se define anteriormente. La aplicación también proporciona composiciones, métodos de tratamiento, y métodos de síntesis de los mismos.
MX2017008162A 2014-12-19 2015-12-18 Sintesis total de trioxacarcina dc-45-a2 y preparacion de analogos de trioxacarcina. MX2017008162A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462094662P 2014-12-19 2014-12-19
US201562186128P 2015-06-29 2015-06-29
PCT/US2015/066703 WO2016100833A2 (en) 2014-12-19 2015-12-18 Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs

Publications (1)

Publication Number Publication Date
MX2017008162A true MX2017008162A (es) 2018-03-06

Family

ID=56127867

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008162A MX2017008162A (es) 2014-12-19 2015-12-18 Sintesis total de trioxacarcina dc-45-a2 y preparacion de analogos de trioxacarcina.

Country Status (23)

Country Link
US (1) US10899773B2 (es)
EP (1) EP3233877A4 (es)
JP (1) JP2017537968A (es)
KR (1) KR20170122718A (es)
CN (1) CN107250144A (es)
AU (1) AU2015364347A1 (es)
BR (1) BR112017013194A2 (es)
CA (1) CA2970955A1 (es)
CL (1) CL2017001599A1 (es)
CO (1) CO2017007074A2 (es)
CR (1) CR20170331A (es)
DO (1) DOP2017000144A (es)
EA (1) EA201791388A1 (es)
EC (1) ECSP17046657A (es)
GT (1) GT201700139A (es)
HK (1) HK1243422A1 (es)
IL (1) IL252947A0 (es)
MA (1) MA41216A (es)
MX (1) MX2017008162A (es)
PE (1) PE20171787A1 (es)
PH (1) PH12017501147A1 (es)
SG (1) SG11201704935XA (es)
WO (1) WO2016100833A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210230178A1 (en) * 2017-08-17 2021-07-29 William Marsh Rice University Trioxacarcin analogs and dimers as potent anticancer agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5815995A (ja) 1981-07-22 1983-01-29 Kyowa Hakko Kogyo Co Ltd Ｄｃ−４５−ａ↓１およびｄｃ−４５−ａ↓２ならびにそれらの製造法
EP0157203A3 (en) 1984-04-04 1986-10-01 American Cyanamid Company Antitumor agents ll-d49194 alpha 1, ll-d49194 beta, ll-d49194 beta 2, ll-d49194 upsilon, ll-d49194 delta, ll-d49194 epsilon, ll-d49194 zeta, and ll-d49194 eta
JPS63135389A (ja) 1986-11-26 1988-06-07 Kyowa Hakko Kogyo Co Ltd Ｄｃ−４５類の誘導体
EP2550285B1 (en) 2010-03-22 2017-07-19 President and Fellows of Harvard College Trioxacarcins and uses thereof
WO2014082065A1 (en) 2012-11-26 2014-05-30 President And Fellows Of Harvard College Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof

Also Published As

Publication number Publication date
MA41216A (fr) 2017-10-24
EP3233877A4 (en) 2018-10-17
US20190023717A1 (en) 2019-01-24
IL252947A0 (en) 2017-08-31
EP3233877A2 (en) 2017-10-25
CA2970955A1 (en) 2016-06-23
CR20170331A (es) 2017-11-17
BR112017013194A2 (pt) 2018-01-02
CN107250144A (zh) 2017-10-13
ECSP17046657A (es) 2019-03-29
HK1243422A1 (zh) 2018-07-13
AU2015364347A1 (en) 2017-07-13
DOP2017000144A (es) 2017-09-29
JP2017537968A (ja) 2017-12-21
PH12017501147A1 (en) 2018-03-05
SG11201704935XA (en) 2017-07-28
WO2016100833A3 (en) 2017-01-05
PE20171787A1 (es) 2017-12-28
WO2016100833A2 (en) 2016-06-23
CO2017007074A2 (es) 2017-10-20
CL2017001599A1 (es) 2018-11-09
US10899773B2 (en) 2021-01-26
KR20170122718A (ko) 2017-11-06
EA201791388A1 (ru) 2017-11-30
GT201700139A (es) 2018-10-24

Similar Documents

Publication Publication Date Title
PH12018500457A1 (en) New phenoxymethyl derivatives
PH12016501192B1 (en) Tetrahydropyridopyrazines modulators of gpr6
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
MX2016002544A (es) Compuestos utiles como inmunomoduladores.
TW201613880A (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
EA033460B1 (ru) Замещенные [1,2,4]триазольные соединения в качестве фунгицидов
MX2019005855A (es) Formulaciones que se pueden pulverizar.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
JO3372B1 (ar) مشتقات 5-بنزيل إيزوكينولين لعلاج أمراض القلب والأوعية الدموية
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
PH12016501613B1 (en) Pyrazines modulators of gpr6
MX2019008375A (es) Tiobenzoimidazol como fungicidas.
TN2016000177A1 (en) P-substituted asymmetric ureas and medical uses thereof
IN2014CH00304A (es)
MX2018015269A (es) Derivados de tailanstatina a, metodos de tratamiento y metodos de sintesis de los mismos.
EA201591449A1 (ru) Способы получения противораковых композиций
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
MX2017005669A (es) Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos.
MX2015015850A (es) Composiciones de sabor y fragancia que contienen tiopiran-carbaldehido.